Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human ROR1 Protein (Fc Tag) (AC1015)
Cat.#: ACPP-1015
Specifications
Despition Recombinant Human ROR1 Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence hFc (Glu99-Ala330) + ROR1 (Lys312-Cys391) Molecular Weight 35.2 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag N-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1118 Human Insulin (Active) (AC1118) 25 mg inquiry ACPP-1112 Recombinant Human Eph Receptor A2 Protein (6×His Tag) (AC1112) 50 µg inquiry ACPP-1253 Pin1 Blocking Peptide (AC1253) 250 µg inquiry ACPP-1553 Human NRG4 Protein (AC1553) 2 µg inquiry ACPP-1631 Human IMPDH1 Protein (AC1631) 2 µg inquiry ACPP-1725 Human GHRL Protein (AC1725) 1 mg inquiry ACPP-1311 Human LIF Protein (AC1311) 3 x 2 µg inquiry ACPP-1435 Human CHGA Protein, His (AC1435) 2 µg inquiry ACPP-1172 Native Human Prostate Specific Antigen (Functional) - Low endotoxin (AC1172) 1 mg inquiry ACPP-1018 Recombinant Human APLP2 Protein (6×His Tag) (AC1018) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket